tiprankstipranks
Trending News
More News >
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market
Advertisement

Chimeric Therapeutics Ltd. (CHM) Revenue

Compare
12 Followers

Chimeric Therapeutics Ltd. Revenue

Chimeric Therapeutics Ltd. had a revenue of 3.57M in the quarter ending Jun 30, 2025, with -35.81%. This bring the company's revenue in the last twelve months to 9.12M, Decreased 140.13%. In the fiscal year ending Dec 31, 2025, Chimeric Therapeutics Ltd. had annual revenue of 3.97M with -46.79% growth.
Revenue (ttm)
9.12M
Revenue Growth
P/S Ratio
2.75
Revenue/Employee
Employees
Market Cap
AU$10.93M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
3.97M-3.49M+53.21%
Dec 31, 2024
7.46M-745,765,800.00%
Dec 31, 2023
-2.62M
Dec 31, 2022
2.62M2.61M+98,946.01%
Dec 31, 2021
2.65K-264,600.00%
Dec 31, 2020
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis